» Articles » PMID: 26460733

Down-regulation of MiR-129-5p Via the Twist1-Snail Feedback Loop Stimulates the Epithelial-mesenchymal Transition and is Associated with Poor Prognosis in Breast Cancer

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Oct 14
PMID 26460733
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial to mesenchymal transition (EMT) plays a pivotal role in breast cancer progression. We found that overexpression of miR-129-5p reversed EMT, whereas depletion of miR-129-5p induced EMT in breast cancer cells. We demonstrated that Twist1 is a direct target of miR-129-5p. Both Twist1 and Snail transcriptionally suppressed miR-129-5p expression. Levels of miR-129-5p were low in breast cancer tissues. miR-129-5p down-regulation correlated with advanced clinical stage and poor prognosis in patients with breast cancer. miR-129-5p expression negatively correlated with Twist1 and Snail expression. Thus, miR-129-5p down-regulation fosters EMT in breast cancer by increasing Twist1-Snail and activating a negative feedback loop.

Citing Articles

Pivotal Role of miRNA-lncRNA Interactions in Human Diseases.

Pooresmaeil F, Azadi S, Hasannejad-Asl B, Takamoli S, Bolhassani A Mol Biotechnol. 2024; .

PMID: 39673006 DOI: 10.1007/s12033-024-01343-y.


Unique miRomics Expression Profiles in -Infected Mandibles during Periodontitis Using Machine Learning.

Aravindraja C, Jeepipalli S, Duncan W, Vekariya K, Bahadekar S, Chan E Int J Mol Sci. 2023; 24(22).

PMID: 38003583 PMC: 10671577. DOI: 10.3390/ijms242216393.


The Expression Levels of Circulating miR-129 and miR-203a in Association with Breast Cancer and Related Metastasis.

Ghalkhani E, Akbari M, Izadi P, Mahmoodzadeh H, Kamali F Iran J Public Health. 2023; 51(12):2808-2816.

PMID: 36742232 PMC: 9874213. DOI: 10.18502/ijph.v51i12.11472.


Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer.

Javdani H, Mollaei H, Karimi F, Mahmoudi S, Farahi A, Mirzaei-Parsa M Mol Biol Rep. 2022; 49(10):9963-9973.

PMID: 35716288 DOI: 10.1007/s11033-022-07553-4.


MiRNA-mediated EMT and CSCs in cancer chemoresistance.

Dong B, Li S, Zhu S, Yi M, Luo S, Wu K Exp Hematol Oncol. 2021; 10(1):12.

PMID: 33579377 PMC: 7881653. DOI: 10.1186/s40164-021-00206-5.


References
1.
Yu J, Xie F, Bao X, Chen W, Xu Q . miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Mol Cancer. 2014; 13:121. PMC: 4040483. DOI: 10.1186/1476-4598-13-121. View

2.
Chen X, Zhang L, Zhang T, Hao M, Zhang X, Zhang J . Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC. Liver Int. 2013; 33(3):476-86. DOI: 10.1111/liv.12097. View

3.
Wu Q, Yang Z, Xia L, Nie Y, Wu K, Shi Y . Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters. Oncotarget. 2014; 5(22):11552-63. PMC: 4294356. DOI: 10.18632/oncotarget.2594. View

4.
Yang Y, Huang J, Zhang X, Shen L . MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell Biochem. 2015; 404(1-2):229-39. PMC: 4544670. DOI: 10.1007/s11010-015-2382-6. View

5.
Ma N, Chen F, Shen S, Chen W, Chen L, Su Q . MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1. Biochem Biophys Res Commun. 2015; 461(4):618-23. DOI: 10.1016/j.bbrc.2015.04.075. View